Xenon Pharmaceuticals Inc. (XENE) Dropped -5.76% or -0.55 To Price $9.0 On Wednesday

Xenon Pharmaceuticals Inc. (XENE) dropped -5.76% or -0.55 to $9.0. It is approximately 183599 shares traded, which is 56.42% compare to the average total volume 325420. The market cap of XENE is $158.51 million. The year to date change is 226.41%. The 52 week price range is from $2.1 to $11.0. Price of XENE have changed 0.53% during last week. It have changed 38.41% over last month, 85.44% over last 3 months, N/A and 189.39% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XENE is 6.90. It is -23.33% below current price. The 200-day Moving Averages for XENE is 4.29. It is -52.33% below current price. The 52-week High is 11.0. It is 22.22% from the current price. The 52-week Low is 2.1. It is -76.67% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of XENE is 1.76 on 2018-06-15. Short % to float is 2.23%. There are some statistics of XENE. It is has market cap $158.51 million. The share outstanding is 17.61 million. The average volume is 325420. The revenue is 279000. The percent of top 15 Institution holding is 69.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XENE is -84.26%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XENE is -54.61%.


Share this post